Rasool, Shafqat
Shomali, Tara
Truong, Luc
Croteau, Nathalie
Veyron, Simon
Bustillos, Bernardo A.
Springer, Wolfdieter
Fiesel, Fabienne C.
Trempe, Jean-François
Funding for this research was provided by:
Mayo Clinic Foundation
National Institutes of Health (RF1 NS085070)
Canadian Institutes of Health Research (153274)
Michael J. Fox Foundation for Parkinson's Research (12119)
Parkinson Canada (2017-1277)
Mitokinin, United States
Article History
Received: 15 December 2023
Accepted: 27 March 2024
First Online: 2 April 2024
Competing interests
: J.-F.T. has consulted for Mitokinin Inc and received compensation. Mayo Clinic, F.C.F., and W.S. have filed a patent related to Parkin activators. All other authors do not possess any conflict of interest.